CVE-2019-15931
9.8
CRITICAL · CVSS 3.1 · EPSS 2.7% (pctl 86)
In your normal cycle
Critical by CVSS (9.8), but no sign of active exploitation.
Description
Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.
Scoring
| CVSS | 9.8 (CRITICAL, v3.1) |
|---|---|
| Vector | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H |
| EPSS | 2.73% — more likely to be exploited than 86% of all CVEs |
| Weakness | CWE-22 |
| On CISA KEV | no |
| Public exploit | none known |
| Published | 2019-12-12 |
| Last modified | 2026-06-17 |
Affected (1)
| Vendor | Product |
|---|---|
| intesync | solismed |
References
- https://bishopfox.com
- https://know.bishopfox.com/advisories/solismed-critical
- https://www.bishopfox.com/blog/news-category/advisories/
- https://www.solismed.com/
- https://bishopfox.com
- https://know.bishopfox.com/advisories/solismed-critical
- https://www.bishopfox.com/blog/news-category/advisories/
- https://www.solismed.com/
→ the Explorer · watch your stack · NVD